Dicloxacillin Sodium hydrate(CAS: 13412-64-1)

Dicloxacillin sodium hydrate (CAS: 13412-64-1) must comply with GHS classification for health hazards, REACH regulations, and FDA/EPA guidelines for pharmaceutical and medicinal uses. It is classified as a Schedule V controlled substance and requires proper labeling and storage for safety and efficacy.

Alternatives to dicloxacillin sodium hydrate include other penicillin derivatives and cephalosporins. Common substitutes in synthesis might include amoxicillin or cephalexin, which offer similar antibacterial properties. Isomers and analogs like dicloxacillin potassium can also be considered in certain formulations.

The market trend for dicloxacillin sodium hydrate shows a steady demand due to its effectiveness against beta-lactamase-producing Staphylococcus aureus. Research is focusing on the development of new antibiotics and resistance management strategies to counter growing bacterial resistance. Price trends are stable, with demand correlating with the prevalence of resistant infections.

Waste containing dicloxacillin sodium hydrate should be collected in appropriate containers, ensuring it is labeled as a hazardous material. It should be handled according to local regulations and guidelines, typically through incineration or professional waste disposal services. Environmental protection measures include proper containment to prevent release into the environment.